The Latest Breaking News from Albert Bourla

Parents of kids under 5 still waiting for COVID shots

The demise of the federal transportation mask mandate was particularly jarring for many parents of children under five anxiously waiting for word on when COVID shots will become available to their kids.

Axios · Apr 20, 2022

mRNA Vaccine Maker CEOs Pocketed $100M In Pandemic Pay: FT

The CEOs of Pfizer Inc (NYSE: PFE), BioNTech SE (NASDAQ: BNTX), and Moderna Inc (NASDAQ: MRNA) have sha

Benzinga · Apr 5, 2022

Pfizer CEO pushes yearly Covid shots

Assertions by pharmaceutical company executives have created pressure for scientists and politicians to take action

Salon · Mar 23, 2022

Pfizer sees Covid-19 drug sales topping $50bn in 2022

NEW YORK - Pfizer forecast more than $50 billion in 2022 sales for its Covid-19 vaccine and therapeutic on Tuesday as the pharmaceutical giant reported a more than doubling of annual profits on strong sales of its innoculation.

Bangkok Post · Feb 9, 2022

Pfizer CEO awarded $1M Genesis Prize for developing COVID vaccine

Albert Bourla is recognised for being at the forefront of fighting the pandemic and developing a vaccine in record time.

Al Jazeera · Jan 19, 2022

Pfizer chief Albert Bourla wins $1 million Genesis Prize

Pfizer's chief executive, Albert Bourla, has been awarded the prestigious Genesis Prize for his efforts in leading the development of a COVID-19 vaccine

The Independent UK · Jan 19, 2022

Four doses not enough to stop omicron

Omicron's vaccine-resistant properties have prompted Pfizer to start work on an omicron-specific vaccine

Salon · Jan 18, 2022